Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parul Kodan

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
The Lancet. Infectious Diseases|November 26, 2021
Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control studyDevashish Desai, Adil Rashid Khan, Manish Soneja, et al.
Drug Discoveries & Therapeutics|November 1, 2021
Post COVID-19 sequelae: A prospective observational study from Northern IndiaShivdas Naik, Soumendra Nath Haldar, Manish Soneja, et al.
The Journal of Infection|January 2, 2022
Risk factors for Coronavirus disease-associated mucormycosisUmang Arora, Megha Priyadarshi, Varidh Katiyar, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
The Lancet. Infectious Diseases|November 26, 2021
Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control studyDevashish Desai, Adil Rashid Khan, Manish Soneja, et al.
Drug Discoveries & Therapeutics|November 1, 2021
Post COVID-19 sequelae: A prospective observational study from Northern IndiaShivdas Naik, Soumendra Nath Haldar, Manish Soneja, et al.
The Journal of Infection|January 2, 2022
Risk factors for Coronavirus disease-associated mucormycosisUmang Arora, Megha Priyadarshi, Varidh Katiyar, et al.
Pageof 5